Are you Dr. Bogusz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 18 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
6.036 Gates
Philadelphia, PA 19104Phone+1 215-615-6510- Is this information wrong?
Summary
- Dr. Agata Bogusz, MD is a board certified pathologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, New Jersey, and Massachusetts.
Education & Training
- Yale-New Haven Medical CenterFellowship, Molecular Genetic Pathology, 2012 - 2013
- Beth Israel Deaconess Medical CenterFellowship, Hematopathology, 2011 - 2012
- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2009
- RWTH Aachen University FOMClass of 1999
Certifications & Licensure
- PA State Medical License 2013 - 2024
- NJ State Medical License 2018 - 2023
- MA State Medical License 2009 - 2014
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 1 citationsInduction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Onc...Qian Zhang, Hong Y Wang, Anindita Nayak, Selene Nunez-Cruz, Artur Slupianek, Xiaobin Liu, Johnvesly Basappa, Jing-Song Fan, Seble Chekol, Reza Nejati, Agata M Bogusz, ...> ;The American Journal of Pathology. 2022 Aug 1
- 17 citationsTransdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome.Qian Zhang, Elena Orlando, Hong Y. Wang, Agata M. Bogusz, Xiaobin Liu, Simon F. Lacey, Honore T. Strauser, Selene Nunez-Cruz, Paul J. Zhang, Sarah Brooks, Christopher ...> ;Blood. 2020 Oct 22
- 29 citationsBrentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Sunita D. Nasta, Sarah J. Nagle, Stefan K. Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren E. Strel...> ;Haematologica. 2020 May 15
- Join now to see all